+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are evaluating the effectiveness and safety of colchicine and non-enteric coated aspirin, alone or combined, in improving cardiovascular outcomes in high-risk adults with type 2 diabetes. This Phase 3 trial focuses on people aged 55 to 80 years who have type 2 diabetes and are at increased risk of cardiovascular events but have no prior history of coronary artery disease-related clinical events. The study aims to prevent serious heart-related problems such as heart attack, stroke, or urgent hospitalizations. Participants are randomly assigned to one of several groups receiving either colchicine 0.5 mg once daily, aspirin 40 mg non-enteric coated tablet twice daily, both, or matching placebos. Those eligible for aspirin therapy are grouped accordingly, while others ineligible for aspirin receive colchicine or placebo. The study uses a factorial design and quadruple masking to fairly evaluate the effects of these drugs over time. During the study, participants are monitored for up to 60 months for cardiovascular events including death, heart attacks, strokes, and hospitalizations for heart conditions. Cognitive function is also assessed yearly using MoCA scores. Researchers collect data on safety, adherence, and outcomes through regular follow-ups to understand how these treatments affect heart health and overall wellbeing in people with type 2 diabetes.

Age: 55Years - 80YearsAll GendersPhase 3
39 locations
I

Actively Recruiting

Fever is a common reason for children aged 3 months to 15 years to visit healthcare providers. It can be hard to tell if the fever is caused by a viral or bacterial infection just by examining the child, which sometimes requires additional tests like measuring C-reactive protein CRP. This study looks at using a capillary medical device to measure CRP directly in primary care to help reduce unnecessary referrals to emergency rooms and labs, improving care for febrile children and easing healthcare system burdens. The study compares two groups one using capillary CRP measurement with the ACTIM-CRP device and a control group without this intervention. Children are randomly assigned to these groups during their primary care visit when they have a fever that meets specific duration and severity conditions. The study runs from September 2025 to June 2027 and focuses on referral rates and other outcomes related to care pathways for febrile children. Participants will be involved in the study during their initial consultation and followed up for up to seven days to monitor referrals, antibiotic prescriptions, satisfaction of both general practitioners and parents, fever duration, and cost impacts. Data on complementary tests and healthcare usage will also be collected to understand the effects of using capillary CRP testing in primary care. The study aims to improve the efficiency and quality of care for children with fever.

Age: 3Months - 15YearsAll GendersPhase Not Applicable
37 locations